BDPARP contains Olaparib 150 mg, a targeted therapy used to treat certain types of ovarian, breast, pancreatic, and prostate cancers. It works by blocking PARP enzymes to help stop cancer cells from repairing themselves.
| Generic Name | Olaparib |
| Manufacturer | BDR |
| Packing | 28 Tablets |
| Prescribed For | Ovarian, Breast, Pancreatic, Prostate cancer |
| Availability | In Stock |
Ribaxa contains Olaparib, a targeted PARP inhibitor used in the treatment of certain types of ovarian, breast, prostate, and pancreatic cancers. It works by blocking cancer cell repair pathways, helping slow or stop tumor growth.
| Generic Name | Olaparib |
| Manufacturer | Dr. Reddy’s |
| Packing | 60 Tablets |
| Prescribed For | Ovarian, Breast, Pancreatic, Prostate cancer |
| Availability | In Stock |
Ibyra (Olaparib 150mg Tablets) is a targeted therapy used to treat ovarian, breast, pancreatic, and prostate cancers with BRCA gene mutations. It works by blocking cancer cell repair, slowing their growth.
| Generic Name | Olaparib |
| Manufacturer | Zydus |
| Packing | 60 Tablets |
| Prescribed For | Ovarian, Breast, Pancreatic, Prostate cancer |
| Availability | In Stock |
Bracanat is an oral anticancer medicine containing Olaparib 150 mg, used to treat BRCA-mutated ovarian, breast, pancreatic, and prostate cancers.
| Generic Name | Olaparib |
| Manufacturer | Natco Pharma Ltd |
| Packing | 30 Tablets in 1 bottle |
| Prescribed For | Ovarian and Breast Cancer |
| Availability | In Stock |
Olabir is an oral anticancer medication containing Olaparib 150 mg, a PARP inhibitor used to treat cancers associated with BRCA gene mutations. It is commonly prescribed for ovarian, breast, pancreatic, and prostate cancers, helping to slow cancer progression and improve survival in advanced stages.
| Generic Name | Olaparib |
| Manufacturer | Aprazer Healthcare Pvt Ltd |
| Packing | 30 Tablets in 1 bottle |
| Prescribed For | Ovarian and Breast Cancer |
| Availability | In Stock |
